49th Annual Meeting
SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT
May 17 – 21, 2008
San Diego Convention Center – San Diego, California
during Digestive Disease Week^®

Program (Subject to Change)
Last Updated 04/09/08

All rooms at the San Diego Convention Center unless otherwise indicated.

	indicates a ticketed session requiring a separate registration and fee.
	indicates the 21 papers also being presented at the Residents & Fellows Research Conference. Participation in and attendance at this conference is by invitation only.

Register now for the SSAT Annual Meeting at Digestive Week 2008. Register for DDW as an SSAT member and save up to $350 off nonmember rates. And don’t forget to supplement your registration with the following additional ticketed events —the SSAT Postgraduate Course and SSAT-sponsored Meet-the-Professor Luncheons

Program and Abstracts | Posters

‹ Back to 2008 Program Index

MONDAY, 5/19/2008
8:00 AM – 8:15 AM		OPENING SESSION (25ABC) Moderator: John C. Bowen, New Orleans, LA Welcome and introduction of new members, announcements of SSAT scholarship awards, reports from the SSAT Foundation, recognition of the Foundation donors, and conferment of the Founders Medal.
8:15 AM – 9:15 AM		PRESIDENTIAL PLENARY A (PLENARY SESSION I) (25ABC) Moderator: Richard A. Prinz, Chicago, IL O1 Stepwise Circumferential and Focal Radiofrequency Ablation of Barrett’s Esophagus with High-Grade Dysplasia or Intramucosal Cancer Roos E. Pouw1, Joep J. Gondrie1, Frederike G. Van Vilsteren1, Carine Sondermeijer1, Wilda Rosmolen1, Wouter L. Curvers1, Lorenza Alvarez Herrero4, Fiebo J. Ten Kate2, Kausilia K. Krishnadath1, Thomas M. Van Gulik3, Paul Fockens1, Bas L. Weusten4, Jacques J. Bergman*1 1Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, Netherlands; 2Pathology, Academic Medical Center, Amsterdam, Netherlands; 3Surgery, Academic Medical Center, Amsterdam, Netherlands; 4Gastroenterology, St. Antonius Hospital, Nieuwegein, Netherlands O2 Long-Term Results of Transanal Excision After Neoadjuvant Chemoradiation for T2 and T3 Adenocarcinomas of the Rectum Rajesh Nair*1, Erin M. Siegel1, Timothy J. Yeatman1, Mokenge P. Malafa1, Jorge Marcet2, David Shibata1 1Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; 2Surgery, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL O3 High Volume Surgery and Outcome After Liver Resection: Surgeon or Center? Robert W. Eppsteiner, Nicholas Csikesz, Jennifer F. Tseng, Shimul A. Shah* Surgery, University of Massachusetts, Worcester, MA O4 Laparoscopic Vertical Sleeve Gastrectomy for Morbid Obesity: A Report of a Five-Year Experience with 750 Patients Crystine M. Lee, Paul T. Cirangle, Gregg H. Jossart* Surgery, California Pacific Medical Center, San Francisco, CA
9:15 AM – 10:00 AM		PRESIDENTIAL ADDRESS (25ABC) SP1 Introduction Richard A. Prinz, Chicago, IL SP2 Evolution of a Surgeon: A 40-Year Perspective John C. Bowen, New Orleans, LA
10:30 AM – 11:15 AM		PRESIDENTIAL PLENARY B (PLENARY SESSION II) (25ABC) Moderator: John C. Bowen, New Orleans, LA O5 Role of Prophylactic Antibiotics in Laparoscopic Cholecystectomy: A Meta-Analysis Abhishek Choudhary*, Matthew L. Bechtold, Craig Karpman, Srinivas R. Puli, Mohamed O. Othman, Praveen K. Roy Department of Internal Medicine, University of Missouri, Columbia, MO O6 Comparison of Surgically Resected Polypoid Lesions of the Gallbladder to Their Pre-Operative Ultrasound Characteristics Martin D. Zielinski*1, Peyton W. Davis1, Florencia G. Que1, Michael L. Kendrick1, Thomas D. Atwell2 1Gastrointestinal and General Surgery, Mayo Clinic, Rochester, MN; 2Radiology, Mayo Clinic, Rochester, MN O7 The Incidental Asymptomatic Pancreatic Lesion: Nuisance or Threat? Teviah E. Sachs*, Wande B. Pratt, Mark P. Callery, Charles M. Vollmer General Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
11:15 AM – 12:00 PM		DORIS AND JOHN L. CAMERON GUEST ORATION (25ABC) SP3 The Coming American Revolution: How China Will Cause the Greatest Changes in the U.S. Since the Birth of the Nation Louis McDaniel Bowen, Hong Kong, SAR, China
12:00 PM – 2:00 PM		POSTER SESSION I (Sails Pavilion) Authors available at their posters to answer questions 12 PM – 2 PM; posters on display 8 AM – 5 PM.
12:30 PM – 1:45 PM		MEET-THE-PROFESSOR LUNCHEONS SP5 What’s New in Liver Tumor Ablation (26A) David M. Mahvi, Madison, WI SP6 Local Therapy for Rectal Cancer (Carlsbad, South Tower, Marriott Hotel & Marina) Michael J. Stamos, Orange, CA
2:15 PM – 3:45 PM		DDW COMBINED CLINICAL SYMPOSIA ESOPHAGEAL CANCER (Ballroom 20A) Sponsored by: SSAT, AGA Moderators: John G. Hunter, Portland, OR Stuart Jon Spechler, Dallas, TX SP7 The Intriguing Epidemiology of Esophageal Cancer: What Factors Underlie the Trends? Stuart Jon Spechler, Dallas, TX SP8 The Biology of Esophageal Cancer: What Factors Influence the Choice of Therapy? Jeffrey H. Peters, Rochester, NY SP9 Endoscopic Treatment of Esophageal Cancer Jacques J. Bergman, Amsterdam, Netherlands SP10 Surgical Treatment of Esophageal Cancer John G. Hunter, Portland, OR SP11 A Balanced Approach to the Treatment of Esophageal Cancer Charles R. Thomas, Jr., Portland, OR Discussion THE OPTIMAL MANAGEMENT OF LGI BLEEEDING (Ballroom 20BCD) Sponsored by: ASGE, AGA, SSAT Moderators: Kenneth R. McQuaid, San Francisco, CA Lisa L. Strate, Seattle, WA SP12 Why Is There So Much Controversy? Lisa L. Strate, Seattle, WA SP13 Should Urgent Colonoscopy Be Performed in Most Patients with Acute LGIB? YES! Dennis M. Jansen, Los Angeles, CA SP14 Should Urgent Colonoscopy Be Performed in Most Patients with Acute LGIB? NO! Don C. Rockey, Dallas, TX
2:15 PM – 5:00 PM		PLENARY SESSION III (24ABC) Moderators: Gerard V. Aranha, Maywood, IL Donald E. Low, Seattle, WA O8 Cervical Nodal Metastasis from Intrathoracic Esophageal Squamous Cell Carcinoma Is Not Necessarily an Incurable Disease Daniel K. Tong*, Simon Law, Kam Ho Wong, John Wong Department of Surgery, The University of Hong Kong, Hong Kong, China O9 The 3-Year Outcome of Optimal Medical or Surgical Management of GERD Patients with Barrett’s Esophagus: The Lotus Trial Experience Stephen E. Attwood*1, Lars R. Lundell2, Jan G. Hatlebakk3, Stefan Eklund4, Ola Junghard4, Jean Paul Galmiche5, Christian Ell6, Roberto Fiocca7, Tore Lind4 1North Tyneside Hospital, North Shields, United Kingdom; 2Karolinska University Hospital Huddinge, Stockholm, Sweden; 3Haukeland Hospital, Bergen, Norway; 4AstraZeneca R&D, Mölndal, Sweden; 5Hotel Dieu-CHU de Nantes, Nantes, France; 6Dr.-Horst-Schmidt-Kliniken Wiesbaden, Wiesbaden, Germany; 7University of Genova, Genova, Italy O10 Zenker's Diverticula: Is a Tailored Approach Feasible? Christian Rizzetto1, Mario Costantini*1, Raffaele Bottin2, Elena Finotti1, Lisa Zanatta1, Martina Ceolin1, Loredana Nicoletti1, Giovanni Zaninotto1, Ermanno Ancona1 1Clinica Chirurgica 3, University of Padua, Padova, Italy; 2Medical and Surgical Specialities, University of Padua, Padua, Italy O11 Quality of Life and Symptomatic Response to Gastric Neurostimulation for Gastroparesis Vic Velanovich* Surgery, Henry Ford Hospital, Detroit, MI O12 Results of the Surgical Treatment of Cardia Carcinoma (Ca) Characterized by Outcome and Perioperative Factors in a Prospective Observational Multicentre Study for Quality Control Lutz Meyer*1, Olof Jannasch2, Frank Meyer2, Hans Lippert2, Ingo Gastinger3 1Surgery, HELIOS Vogtland Hospital Plauen, Plauen, Germany; 2Surgery, University Hospital Magdeburg, Magdeburg, Germany; 3Surgery, Carl Thiem Hospital Cottbus, Cottbus, Germany O13 Probiotics Improve Weight Loss, GI-Related Quality of Life and H2 Breath Tests After Gastric Bypass Surgery: A Prospective Randomized Trial Gavitt a. Woodard*, Joseph Peraza, John Downey, Betsy Encarnacion, John M. Morton Surgery, Stanford School of Medicine, Stanford, CA O14 Factors Related to Anastomotic Dehiscence and Mortality After Terminal Stomal Closure in the Management of Patients with Severe Secondary Peritonitis Jose L. Martinez*, Pablo Andrade, Enrique Luque-De-Leon Gastrocirugía, UMAE Hospital Especialidades Centro Médico Nacional SXXI, Mexico DF, Mexico O15 Predictors of Survival in 865 Patients with Acinar Cell Carcinoma of the Pancreas: Survival After Surgery Compared to Ductal Adenocarcinoma C. Max Schmidt*1,4, Jesus M. Matos1, David J. Bentrem3, Mark S. Talamonti2, Keith D. Lillemoe1, Karl Y. Bilimoria3 1Department of Surgery, Indiana University School of Medicine, Indianapolis, IN; 2Department of Surgery, Evanston Northwestern Healthcare, Evanston, IL; 3Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL; 4Department of Biochemistry/Molecular Biology, Indiana University School of Medicine, Indianapolis, IN O16 Preoperative Liver Function Tests and Hemoglobin Will Predict Complications Following Pancreaticoduodenectomy Christopher D. Hughes*1, Karen Rychlik2, Margo Shoup1, Gerard V. Aranha1 1Department of Surgery, Division of Surgical Oncology, Loyola University Medical Center, Maywood, IL; 2The Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL O17 Surgical Management of Early Hepatocellular Carcinoma: Resection or Transplantation? Emily C. Bellavance*2, Steven Cunningham2, Kimberly M. Lumpkins2, Warren R. Maley1, Cinthia Drachenberg3, Richard D. Schulick1, Andrew M. Cameron1, Michael Choti1, Nader Hanna2, Benjamin Philosophe2, Timothy M. Pawlik1 1Surgery, Johns Hopkins Hospital, Baltimore, MD; 2Surgery, University of Maryland, Baltimore, MD; 3Pathology, University of Maryland, Baltimore, MD O18 Increasing Regionalization of Hepatic Resection in Canada: 1995-2004 Ryan McColl*, Xiaoqing You, William A. Ghali, Elijah Dixon Department of Surgery, Medicine, and Community Health Sciences, University of Calgary, Calgary, AB, Canada
2:15 PM – 5:00 PM		SSAT/AGA/ASGE STATE-OF-THE-ART CONFERENCE OPTIMAL TIMING OF SURGERY FOR IBD (25ABC) Moderator: Richard A. Hodin, Boston, MA SP15 Introduction Richard A. Hodin, Boston, MA SP16 Pregnancy: Before, During, and After Robin S. McLeod, Toronto, ON SP18 An Updated Approach to Dysplasia in IBD David Rubin, Chicago, IL SP19 Fulminant Colitis Bruce Sands, Boston , MA SP20 Pyogenic Complications of Crohns James W. Fleshman, St. Louis, MO Case Presentations Q&A
2:30 PM – 4:00 PM		VIDEO SESSION I: HPB SURGERY (27B) Moderators: Rebecca M. Minter, Ann Arbor, MI Randall S. Zuckerman, Cooperstown, NY V1 The Lateral Laparoscopic Approach to Lesions in the Posterior Segments Andrew A. Gumbs*1,2, Brice Gayet2 1Upper GI and Endocrine Surgery, New York-Presbyterian Hospital, New York, NY; 2Medical and Surgical Department of Digestive Diseases, Institut Mutualiste Montsouris, Paris, France V2 Small Diameter Prosthetic H-Graft Portacaval Shunt for Portal Decompression Alexander S. Rosemurgy*, Harold Paul, Mark Shapiro, Desiree Villadolid, Sam Al-Saadi, Sharona B. Ross, Sarah Cowgill Surgery, University of South Florida and Tampa General Hospital, Tampa, FL V3 Functional Magnetic Resonance Imaging of Pancreatic Disease Tara S. Kent*1, Ivan Pedrosa3, Sunil Sheth2, Alphonso Brown2, Mark P. Callery1, Charles M. Vollmer1 1Surgery, Beth Israel Deaconess Medical Center, Boston, MA; 2Medicine, Beth Israel Deaconess Medical Center, Boston, MA; 3Radiology, Beth Israel Deaconess Medical Center, Boston, MA V4 Laparoscopic Extended Distal Pancreatectomy for Tumors of the Pancreatic Neck Christos A. Galanopoulos*, D. Rohan Jeyarajah HPB/Foregut Surgery, Methodist Dallas Medical Center, Dallas, TX V5 Laparoscopic Approach in Patients with Gastrinoma Which Are the Limits? Laureano Fernández-Cruz* Surgery, Hospital Clínic, Barcelona, Spain
4:00 PM – 5:30 PM		DDW COMBINED CLINICAL SYMPOSIA MEDICAL AND SURGICAL MANAGEMENT OF NAFLD (Ballroom 20BCD) Sponsored by: AASLD, SSAT Moderators: Nathan M. Bass, San Francisco, CA John M. Morton, Stanford, CA SP21 The Pathogenesis of NAFLD: The Rational Basis for Treatment Strategies Stephen H. Caldwell, Charlottesville, VA SP22 The Medical Management of NAFLD Paul Angulo, Rochester, MN SP23 The Surgical Management of NAFLD John M. Morton, Stanford, CA PANCREATIC CANCER (Ballroom 20A) Sponsored by: SSAT, ASGE, AGA Moderators: William R. Brugge, Boston, MA Douglas B. Evans, Houston, TX SP23.5 The Importance of Pretreatment Radiographic Staging: Definitions of Resectable, Borderline Resectable and Locally Advanced Pancreatic Cancer Chuslip Charnsangavej, Houston, TX SP24 Preoperative Biliary Stenting for Resectable Disease: Current Controversy and the Role for Metal vs. Plastic Peter B. Kelsey, Boston, MA SP25 Endoscopic Ultrasound-Guided FNA: Should It Be Routine in Patients with Localized Pancreatic Cancer Michael J. Levy, Rochester, MN SP26 Patient Selection for Surgery: Diagnostic and Treatment Sequencing Mark P. Callery, Boston, MA Case Presentations